Brandywine Global Investment Management LLC Grows Position in Healthpeak Properties, Inc. $DOC

Brandywine Global Investment Management LLC increased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 1.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 3,446,910 shares of the real estate investment trust’s stock after purchasing an additional 62,006 shares during the period. Brandywine Global Investment Management LLC’s holdings in Healthpeak Properties were worth $55,426,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. State Street Corp increased its holdings in Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after acquiring an additional 895,460 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Healthpeak Properties by 8.6% during the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after buying an additional 2,438,278 shares in the last quarter. Geode Capital Management LLC grew its holdings in Healthpeak Properties by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after buying an additional 123,274 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Healthpeak Properties by 4.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock worth $195,873,000 after acquiring an additional 400,900 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock worth $190,292,000 after acquiring an additional 2,206,222 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on DOC shares. UBS Group increased their target price on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, May 13th. Royal Bank Of Canada upped their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Scotiabank boosted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Finally, Wells Fargo & Company increased their price target on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Four research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $19.38.

Healthpeak Properties Stock Up 0.0%

Shares of NYSE:DOC opened at $19.80 on Monday. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $20.27. The stock has a market cap of $13.65 billion, a P/E ratio of 61.87, a price-to-earnings-growth ratio of 3.09 and a beta of 1.05. The business’s 50 day moving average is $17.96 and its 200 day moving average is $17.39. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Sell-side analysts predict that Healthpeak Properties, Inc. will post 1.74 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.23% of the stock is owned by corporate insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.